1. Various tissues will have different safe zones of rejuvenation before they become pluripotent but we could make tissue specific treatments and treat them separately without effecting others.
2. A 40 year old woman makes a 40 year old egg but that egg is rejuvenated to its younger state with no damage after fertilization.
I share this revealing interview given by Liz Parrish, “Patient Zero” in biological rejuvenation, to a journalist in Madrid, Spain. It took place in July 10, 2022 and lasts 20 minutes.
During the interview Liz speaks in English. However, the journalist, whose name is María Zabay, speaks mostly in Spanish.
Don’t miss it because Liz says things that most people don’t know about her and her company BioViva Sciences.
Liz Parrish, patient zero in gene therapy for full-body and brain biological rejuvenation, is interviewed by María Zabay.
María is a writer, speaker, director and host of television programs, as well as actress.
Researchers at Cornell University have come up with a novel biomaterial that can be used to create artificial skin capable of mimicking the behavior of natural human tissues.
Thanks to its unique composition, made up of collagen mixed with a ‘zwitterionic’ hydrogel, the team’s biohybrid composite is said to be soft and biocompatible, but flexible enough to withstand continued distortion. While the scientists’ R&D project remains ongoing, they say their bio-ink could one day be used as a basis for 3D printing scaffolds from patients’ cells, which effectively heal wounds in-situ.
“Ultimately, we want to create something for regenerative medicine purposes, such as a piece of scaffold that can withstand some initial loads until the tissue fully regenerates,” said Nikolaos Bouklas, one of the study’s co-lead authors. “With this material, you could 3D print a porous scaffold with cells that could eventually create the actual tissue around the scaffold.”
A new King’s-led study, published in the Proceedings of the National Academy of Sciences, has found that a single factor (a protein coding gene known as Sox8) can make non-ear cells adopt ear character during embryo development. The findings not only demonstrate how cell fate decisions are regulated in the embryo but may also inform reprogramming and regenerative strategies for the ear developmental malformations.
Responsible for the sense of hearing and balance, the inner ear is critically important for communication with the environment. In humans, developmental malformations of the ear have life-long consequences, while age-related hearing defects affect a large proportion of the population. Currently, there are no therapies that involve biological approaches—only hearing aids or cochlear implants, as how the ear normally develops is not fully understood and many of the controlling factors are poorly characterized.
Researchers from the Faculty of Dentistry, Oral and Craniofacial Sciences at King’s, in collaboration with colleagues from the Francis Crick Institute, explored the earliest steps in ear development to determine what causes cells to become ear cells, and what makes them different from cells which form other sense organs.
In this landmark talk, Peter Diamandis shares how we are rapidly heading towards a human-scale transformation, the next evolutionary step into what he calls a “Meta-Intelligence,” a future in which we are all highly connected — brain to brain via the cloud — sharing thoughts, knowledge and actions. He highlights the 4 driving forces as well as the 4 steps that is transforming humanity.
In 2014 Fortune Magazine named Peter Diamandis as one of the World’s 50 Greatest Leaders.
Diamandis He is the Founder & Executive Chairman of the XPRIZE Foundation which leads the world in designing and operating large-scale incentive competitions. He is also the Co-Founder & Exec Chairman of Singularity University, a graduate-level Silicon Valley institution that counsels the world’s leaders on exponentially growing technologies.
As an entrepreneur, Diamandis has started 17 companies. He is the Co-Founder and Vice-Chairman of Human Longevity Inc. (HLI), a genomics and cell therapy-based company focused on extending the healthy human lifespan, and Co-Founder and Co-Chairman of Planetary Resources, a company designing spacecraft to enable the detection and prospecting of asteroid for fuels and precious materials.
Peter Diamandis earned degrees in Molecular Genetics and Aerospace Engineering from the MIT, and holds an M.D. from Harvard Medical School.
This talk was given at a TEDx event using the TED conference format but independently organized by a local community.
http://2045.comhttp://gf2045.com. In February of 2012 the first Global Future 2045 Congress was held in Moscow. There, over 50 world leading scientists from multiple disciplines met to develop a strategy for the future development of humankind. One of the main goals of the Congress was to construct a global network of scientists to further research on the development of cybernetic technology, with the ultimate goal of transferring a human’s individual consciousness to an artificial carrier.
2012–2013. The global economic and social crises are exacerbated. The debates on the global paradigm of future development intensifies.
New transhumanist movements and parties emerge. Russia 2045 transforms into World 2045.
Simultaneously, the 2045.com international social network for open innovation is expanding. Here anyone interested may propose a project, take part in working on it, or fund it, or both. In the network, there are scientists, scholars, researchers, financiers and managers.
2013–2014. New centers working on cybernetic technologies for the development of radical life extension rise. The ‘race for immortality’ starts.
2015–2020. The Avatar is created — A robotic human copy controlled by thought via ‘brain-computer’ interface. It becomes as popular as a car.
MAUI, Hawaii—(BUSINESS WIRE)—Extended Longevity, a Hawaii-based longevity company focused on reversing the biomarkers of aging, announces that new test results show the regrowth of telomeres in a 75 year old man to the equivalent of a 10 year old (a 65 year reversal), using the SpectraCell Laboratories Telomere test. Thus, this demonstrates that his aging process, as represented by telomere biomarker tests, has significantly regenerated.
Continuously updated results from third-party testing labs demonstrating how well our products work in the real world.
Aging (Aging-US) and FOXO Technologies have teamed up to present a special collaboration on aging research with a new monthly video series: the Longevity & Aging Series. This series of video interviews invites Aging researchers to speak with researcher and host Dr. Brian Chen. Dr. Chen is an adjunct faculty member at the Herbert Wertheim School of Public Health and Human Longevity Science at the University of California San Diego. He is also the Chief Science Officer of FOXO Technologies.
In the first episode of the Longevity & Aging Series, Drs. Alex Zhavoronkov and Frank Pun discuss, in detail, their recently published research paper, “Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine.”
Regenerage global LLC expanding clinical network to UAE.
ABU DHABI, United Arab Emirates (PRWEB) July 5, 2022.
Regenerage Global LLC, an emerging global leader in clinical, integrative regenerative healthcare and longevity, in collaboration with Aesthetic Polyclinic / Reviv UAE, a medical spa and polyclinic based in Abu Dhabi, Dubai and Al Ain, specializing in plastic surgery, dermatology, dental services and aesthetic services, announce the establishing of Regenerage Clinic Abu Dhabi.
“We are extremely excited about this collaboration and the establishing of Regenerage Clinic Abu Dhabi”, said Dr. Kristofer T. Chaffin, President & CEO, Regenerage Global LLC. “Together with our two existing clinical locations in Cancun and Mexico City, and future sites shortly coming online in Eastern Europe and Southeast Asia, we continue to execute on our global strategy of building the ‘Starbucks®’ of regenerative healthcare and longevity.”